Simone Niclou
Latest publications
Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies.
- NORLUX Neuro-Oncology Laboratory
2014 Sep. Adv Drug Deliv Rev.76:98-115. Epub 2014 Jul 28.
PeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species.
- NORLUX Neuro-Oncology Laboratory
- Proteomics of Cellular Signaling
2014 Sep. Front Genet.5:305.
Factors influencing the mechanical stability of alginate beads applicable for immunoisolation of mammalian cells.
- NORLUX Neuro-Oncology Laboratory
2014 Sep. J Mech Behav Biomed Mater.37:196-208. Epub 2014 Jun 2.
Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?
- NORLUX Neuro-Oncology Laboratory
2014 Aug. Biochim Biophys Acta-Rev Cancer 1846(1):66-74. Epub 2014 Apr 18.
Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture.
- NORLUX Neuro-Oncology Laboratory
2014 Jul. Proteome Sci.12:39.
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.
- NORLUX Neuro-Oncology Laboratory
2014 May. Cancer Med.3(4):812-24. Epub 2014 May 8.
Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment?
- NORLUX Neuro-Oncology Laboratory
2014 May. Neuro Oncol.16(5):754-6.
Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
- NORLUX Neuro-Oncology Laboratory
2014 Apr. Adv Drug Deliv Rev.67-68:142-53. Epub 2014 Jan 31.
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.
- NORLUX Neuro-Oncology Laboratory
- Platform National Cytometry
- Platform LUXGEN - Micro-Array
2014 Feb. Acta Neuropathol.127(2):203-1. Epub 2013 Oct 24.
Tumor versus stromal cells in culture--survival of the fittest?
- NORLUX Neuro-Oncology Laboratory
2013 Dec. PLoS One.8(12):e81183.
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
2013 Oct. Proc Natl Acad Sci U S A.110(43):17450-5. Epub 2013 Oct 7.
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.
- NORLUX Neuro-Oncology Laboratory
2013 Sep. Neuro Oncol.15(9):1200-11. Epub 2013 May 30.
Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model.
- NORLUX Neuro-Oncology Laboratory
2013 Jul. PLoS One.8(7):e68288.
Combined effect of tissue stabilization and protein extraction methods on phosphoprotein analysis.
- Integrated BioBank of Luxembourg
- NORLUX Neuro-Oncology Laboratory
2013 Jun. Biopreserv Biobank.11(3):161-5.
In vivo animal models for studying brain metastasis: value and limitations.
- NORLUX Neuro-Oncology Laboratory
2013 Jun. Clin Exp Metastasis.30(5):695-710. Epub 2013 Jan 16.
Increased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG.
- NORLUX Neuro-Oncology Laboratory
2013 May. Acta Neuropathol Commun.1:18.
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.
- NORLUX Neuro-Oncology Laboratory
- Platform National Cytometry
- Platform LUXGEN - Micro-Array
2013 May. Brain.136(Pt 5):1462-75. Epub 2013 Mar 4.
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis.
- NORLUX Neuro-Oncology Laboratory
2013 May. Acta Neuropathol.125(5):683-98. Epub 2013 Feb 22.
A novel, diffusely infiltrative xenograft model of human anaplastic oligodendroglioma with mutations in FUBP1, CIC, and IDH1.
- NORLUX Neuro-Oncology Laboratory
2013 Mar. PLoS One.8(3):e59773. Epub 2013 Mar 19.
Animal models for low-grade gliomas. In Diffuse Low-Grade Gliomas in Adults. 1st ed. (Book Chapter)
- NORLUX Neuro-Oncology Laboratory
2013 Mar. Duffau H, ed. Berlin: Springer, 2013. p.165-175. ISBN 978-1-4471-2212-8.